AOTI Inc, the global leader in multi-modality topical wound oxygen, announced exciting news from the 9th International Symposium on the Diabetic Foot (ISDF). The IWGDF has recognized the efficacy of topical oxygen therapy in their 2023 Diabetic Foot Ulcer Guidelines, further endorsing AOTI Inc.’s innovative treatment approach.
OCEANSIDE, Calif., Dec. 13, 2022 /PRNewswire/ — Advanced Oxygen Therapy Inc. (AOTI), the global leader in noninvasive topical oxygen wound healing solutions, announced today that the American Diabetes Association has awarded an “A” grade...
OCEANSIDE, Calif., March 23, 2022 /PRNewswire/ — Advanced Oxygen Therapy Inc. (AOTI), the global leader in noninvasive topical oxygen wound healing solutions, announced today that is has received Chinese National Medical Products Administration (NMPA), commonly...
OCEANSIDE, Calif., Feb. 14, 2022 /PRNewswire/ — Advanced Oxygen Therapy Inc. (AOTI), the leader in noninvasive sustained wound healing solutions, announced today a number of significant additions to its Leadership Team, bringing to the company over 100 years of...
Please join us at the Florida Podiatric Medical Association Conference in Orlando, Florida where we will be showcasing TWO2, our unique multi-modality topical oxygen therapy, recently shown through research in a Real World Evidence study to significantly reduce...
